Brazil In-vitro Toxicology Testing Market Size & Outlook
Brazil in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
Brazil in-vitro toxicology testing market highlights
- The Brazil in-vitro toxicology testing market generated a revenue of USD 594.5 million in 2023 and is expected to reach USD 1,107.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
| Market revenue in 2023 | USD 594.5 million |
| Market revenue in 2030 | USD 1,107.0 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.9% of the global in-vitro toxicology testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 873.1 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 43.21% in 2023. Horizon Databook has segmented the Brazil in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil has a growing market for in vitro toxicology testing, and competition among pharmaceutical and biotechnology companies is increasing. The country has a favorable regulatory environment and a growing number of accredited laboratories are providing in vitro toxicology testing services.
The increasing demand for in vitro testing in Brazil was driven by the need to reduce animal testing, improve drug safety & efficacy, and comply with regulatory requirements. Brazil has emphasized the implementation of alternative toxicity testing approaches for products across various industries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil in-vitro toxicology testing market size, by end user, 2018-2030 (US$M)
Brazil In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
